Latest Competition News

Simonds Group Limited has agreed to acquire Dennis Family Homes for an estimated $10 million, significantly broadening its product portfolio and market presence in Victoria and New South Wales. The deal is expected to boost revenue by $200 million in FY26 and be earnings accretive by Q1 FY26.

GreenHy2 Limited reports a slight cash decline but strengthens its foothold in renewable energy with key partnerships and strategic pivots in hydrogen storage technology.

Elixir Energy wraps up Daydream-2 well operations and prepares for next appraisal in a strengthening gas market, while progressing farmout talks for Australian and Mongolian assets.

Australian Dairy Nutritionals Limited reports improved cash flow in Q2 FY25 and prepares for the strategic launch of its premium Future brand in China, aiming to reshape its growth trajectory.

Telix Pharmaceuticals has completed a strategic acquisition of ImaginAb, gaining next-generation therapeutic assets and a novel biologics platform to expand its oncology pipeline and R&D capabilities.

Loyal Lithium Limited has consolidated its position in North America’s lithium sector through a key acquisition and promising exploration results, positioning itself strongly for 2025.

Mach7 Technologies reports a robust Q2 FY25 with a 15.6% increase in Contracted Annual Recurring Revenue, reaffirming its FY25 growth guidance and initiating a $5 million share buy-back.

Norwood Systems has secured a fifth variation to its cash drawdown facility, increasing the principal to $720,114 and extending repayment to mid-February 2025. The move underscores ongoing financial support from a key director amid evolving capital needs.

Immutep Limited has initiated its pivotal Phase III trial for eftilagimod alfa in first-line non-small cell lung cancer, supported by compelling survival outcomes from ongoing studies and a robust cash position expected to fund operations through 2026.

Earth's Energy Limited reports promising progress in its Paralana and Flinders West geothermal projects, confirming new development zones and initiating joint venture discussions, while maintaining a solid cash position.

Optiscan Imaging Ltd has secured a $1.775 million R&D tax refund for FY24, more than doubling last year’s amount thanks to expanded claims on overseas research. The boost will fund ongoing development of its cutting-edge confocal laser endomicroscopy technology.

St Barbara has secured A$100 million to fast-track its Simberi Sulphides project, aiming to bring forward production by up to five months, even as Q2 gold output fell short of expectations due to operational challenges.